by HealthDay Reporter | May 2, 2024
Women have increased risk for thyroid, renal, lung cancers; men have highest risk for melanoma, bladder, prostate cancers. Patients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according...
by HealthDay Reporter | Apr 30, 2024
Two-thirds of mothers of newborns with SCD live in counties with high, very high levels of social vulnerability. The crude sickle cell disease (SCD) birth prevalence is 28.54 per 10,000 non-Hispanic Black newborns, according to research published in the...
by HealthDay Reporter | Apr 29, 2024
Phase 3 trial shows 51 percent reduction in the risk for disease progression or death in triple-class exposed patients. The U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for...
by HealthDay Reporter | Apr 26, 2024
Injectable treatment is an activin signaling inhibitor, representing a new class of therapy. The U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults....
by HealthDay Reporter | Apr 24, 2024
Reduction in relapse incidence observed over time, as well as improvement in leukemia-free survival, overall survival. For older patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic cell transplantation (allo-HCT),...
